Retrospective analysis of synthetic cannabinoids in serum samples - epidemiology and consumption patterns

Forensic Science International

Volumn 242, Issue , 2014, Pages 81-87

  Jaenicke, Nathalie J ^a   Pogoda, Werner ^a   Paulke, Alexander ^a   Wunder, Cora ^a   Toennes, Stefan W ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Consumption patterns; Driving impairment; Driving under the influence of drugs (DUID); Forensic toxicology; Prevalence; Synthetic cannabinoids

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; ALCOHOL; AM 1172; AM 1220; AM 2201; AM 2233; CANNABINOID; CB 25; CB 52; CB 86; JWH 007; JWH 011; JWH 016; JWH 019; JWH 020; JWH 030; JWH 073; JWH 081; JWH 098; JWH 122; JWH 182; JWH 200; JWH 203; JWH 250; JWH 398; O 2545; UNCLASSIFIED DRUG; DESIGNER DRUG;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CRIMINAL BEHAVIOR; DRUG USE; GERMANY; HUMAN; MASS SPECTROMETRY; PARANOIA; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; ADOLESCENT; BLOOD; CRIMINAL LAW; LIQUID CHROMATOGRAPHY; MALE; MIDDLE AGED; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; CANNABINOIDS; CHROMATOGRAPHY, LIQUID; CRIMINAL LAW; DESIGNER DRUGS; GERMANY; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; RETROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84904560744     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2014.06.010     Document Type: Article

References (32)

1. C. Steup, Untersuchung des Handelsproduktes "Spice" , 2008 (accessed 30.04.14.). http://www.eve-rave.ch/Images/analyse-thc-pharm-spice-jwh-018.pdf.
2. Auwärter V., Dresen S., Weinmann W., Müller M., Pütz M., Ferreirós N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?. J. Mass Spectrom. 2009, 44:832-837.
3. European Monitoring Centre for Drugs and Drug Addiction, Perspektive on Drugs-Synthetic cannabinoids in Europe. , 2013 (accessed 30.04.14.). http://www.emcdda.europa.eu/topics/pods/synthetic-cannabinoids.
4. Pabst A., Piontek D., Kraus L., Müller S. Substance use and substance use disorders: results of the 2009 epidemiological survey of substance abuse. Sucht 2010, 56:327-336.
5. Home Office , Drug Misuse Declared: Findings from the 2011/12Crime Survey for England and Wales 2nd edition. , 2012 (accessed 30.04.14.). http://https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/147938/drugs-misuse-dec-1112-pdf.pdf.
6. A. Winstock, MixMag/Global drugs survey. , 2012 (accessed 30.04.14.). http://issuu.com/mixmagfashion/docs/drugs_survey_2012_2/1%3Fe=0.
7. Heltsley R., Shelby M.K., Crouch D.J., Black D.L., Robert T.A., Marshall L., Bender C.L., DePriest A.Z., Colello M.A. Prevalence of synthetic cannabinoids in U. S. athletes: initial findings. J. Anal Toxicol 2012, 36:588-593.
8. Berry-Caban C.S., Kleinschmidt P.E., Rao Jenkins D.S.J. Synthetic cannabinoid and cathinone use among us soldiers. US Army Med. Dep J. 2012, 19-24.
9. Tuv S.S., Krabseth H., Karinen R., Olsen K.M., Øiestad E.L., Vindenes V. Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period. Accid. Anal. Prev. 2014, 62:26-31.
10. Auwärter V., Dargan P.I., Wood D.M. Synthetic cannabinoid receptor agonists. Novel Psychoactive Substances: Classification, Pharmacology and Toxicology 2013, 317-343. Elsevier/Academic Press, Amsterdam, Boston. P.I. Dargan, D.M. Wood (Eds.).
11. Kneisel S., Auwärter V. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. J. Mass Spectrom. 2012, 47:825-835.
12. Peters F.T., Hartung M., Herbold M., SChmitt G., Daldrup T., Mußhoff F. Anhang B zu den Richtlinien der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen: Anforderungen an die Validierung von Analysemethoden. Toxichem Krimtech 2009, 76:185-208.
13. Peters F.T., Drummer O.H., Musshoff F. Validation of new methods. Forensic Sci. Int. 2007, 165:216-224.
14. Kolb M., Bahr A., Hippich S., Schulz W. Calculation of detection limit, identification limit and determination limit according to DIN 32645 with the aid of a computer program. Acta. hydrochim. hydrobiol. 1993, 21:308-311.
15. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.
16. Auwärter V., Kneisel S., Hutter M., Thierauf A. Synthetische Cannabinoide. Rechtsmedizin 2012, 22:259-271.
17. Kronstrand R., Roman M., Andersson M., Eklund A. Toxicological findings of synthetic cannabinoids in recreational users. J. Anal. Toxicol. 2013, 37:534-541.
18. Hermanns-Clausen M., Kneisel S., Szabo B., Auwärter V. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction 2013, 108:534-544.
19. Schneir A.B., Cullen J., Ly B.T. "Spice" girls: synthetic cannabinoid intoxication. case report. J. Emerg. Med. 2011, 40:296-299.
20. Forrester M.B., Kleinschmidt K., Schwarz E., Young A. Synthetic cannabinoid exposures reported to Texas poison centers. J. Addict. Dis. 2011, 30:351-358.
21. Musshoff F., Madea B., Kernbach-Wighton G., Bicker W., Kneisel S., Hutter M., Auwärter V. Driving under the influence of synthetic cannabinoids ("Spice"): a case series. Int. J. Legal Med. 2014, 128:59-64.
22. Werse B., Morgenstern C. How to handle legal highs? Findings from a German online survey and considerations on drug policy issues. Drugs Alcohol Today 2012, 12:222-231.
23. Porter A.C., Felder C.C. The endocannabinoid nervous system. Pharmacol. Ther. 2001, 90:45-60.
24. Zimmermann U.S., Winkelmann P.R., Pilhatsch M., Nees J.A., Spanagel R., Schulz K. Withdrawal phenomena and dependence syndrome after the consumption of "spice gold". Dtsch. Arztebl Int. 2009, 106:464-467.
25. Rominger A., Cumming P., Xiong G., Koller G., Förster S., Zwergal A., Karamatskos E., Bartenstein P., La Fougère C., Pogarell O. Effects of acute detoxification of the herbal blend 'Spice Gold' on dopamine D2/3 receptor availability: a [18F]fallypride PET study. Eur. Neuropsychopharmacol. 2013, 23:1606-1610.
26. European Monitoring Centre for Drugs and Drug Addiction, EU drug markets report: A strategic analysis. , 2013 (accessed 30.04.14.). http://www.emcdda.europa.eu/publications/joint-publications/drug-markets.
27. B. Werse, O. Müller, C. Schell, C. Morgenstern, MoSyD-Jahresbericht 2010: Drogentrends in Frankfurt am Main, 2011 (accessed 30.04.14.). http://www.frankfurt.de/sixcms/media.php/738/MoSyD-Jahresbericht%202010%20%20Gesamtdokument.pdf.
28. Clinical Committee of the Government Delegation for the National Plan on Drugs, Emerging drugs, Ministry of Health Social policy and Equality Madrid. 2011.
29. Hu X., Primack B.A., Barnett T.E., Cook R.L. College students and use of K2: an emerging drug of abuse in young persons. Subst. Abuse Treat. Prev Policy 2011, 6:16.
30. Center for Substance Abuse Research, CESAR FAX Synthetic Cannabinoid Series. , 2011-2014 (accessed 30.04.l4.). http://www.cesar.umd.edu/cesar/pubs/SyntheticCannabinoidCESARFAX.pdf.
31. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E. Monitoring the Future-National Survey Results on Drug Use, 1975-2012: volume 2: College Students and Adults Aged 19K50 2013, Institute for Social Research, The University of Michigan, Ann Arbor.
32. Wood D.M., Hunter L., Measham F., Dargan P.I. Limited use of novel psychoactive substances in South London nightclubs. QJM 2012, 105:959-964.